Vivimed Labs Limited (NSE:VIVIMEDLAB)

India · Delayed Price · Currency is INR

5.07

-0.07 (-1.36%)

Jul 31, 2026, 3:29 PM IST

Vivimed Labs Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	763.08	763.08	1,206	1,590	1,881	2,386
Revenue Growth	-36.75%	-36.75%	-24.15%	-15.43%	-21.16%	-72.62%
Gross Profit	25.61	25.61	590.21	867.76	-864.86	828.14
Operating Income	-1,722	-1,722	-288.5	-418.07	-2,051	-250.73
Net Income	-1,765	-1,765	-319.61	-454.46	-3,285	-676.5
Earnings Per Share	-21.15	-21.15	-3.85	-5.48	-39.62	-8.16
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	908.21	1,406	1,680	2,308
Export	254.48	84.32	191.13	58.2
Total	1,163	1,491	1,871	2,373

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	13.56	13.56	7.08	20.26	37.62	71.84
Total Debt	3,973	3,973	3,763	3,788	3,810	3,589
Net Cash (Debt)	-3,960	-3,960	-3,756	-3,768	-3,773	-3,517
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-47.46	-47.46	-45.30	-45.44	-45.50	-42.42

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	77.03	77.03	-17.51	-239.91	353.22	275.4
Capital Expenditures	-9.47	-9.47	-45.31	-20.39	-49.68	-164.1
Free Cash Flow	67.56	67.56	-62.82	-260.3	303.54	111.3
Free Cash Flow Growth	-	-	-	-	172.72%	-98.04%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	3.36%	3.36%	48.92%	54.56%	-45.99%	34.72%
Operating Margin	-225.62%	-225.62%	-23.91%	-26.29%	-109.03%	-10.51%
Pretax Margin	-231.08%	-231.08%	-26.40%	-28.81%	-175.82%	-27.18%
Profit Margin	-231.26%	-231.26%	-26.49%	-28.57%	-174.69%	-28.36%
FCF Margin	8.85%	8.85%	-5.21%	-16.37%	16.14%	4.67%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Forward PE	-	3.14	3.14	3.14	3.14	3.14
P/FCF Ratio	6.23	6.48	-	-	1.80	10.80
PS Ratio	0.55	0.57	0.34	0.26	0.29	0.50